Together, this study suggests that the activation of SHP2 and RhoA/ROCK may play a significant role in regulating eosinophil recruitment in allergic asthma, and blockage of the SHP2‐RhoA signalling pathway represents a promising approach for the treatment of allergic asthma. Here, PTPN11 is linked to allergic asthma.